Page last updated: 2024-11-03

riluzole and Chronic Illness

riluzole has been researched along with Chronic Illness in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
"We aimed to assess the efficacy and tolerability of riluzole, an anti-glutamate agent with neuroprotective properties, as an adjunct to risperidone in improving negative symptoms of schizophrenia."9.19A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia. ( Akhondzadeh, S; Farokhnia, M; Hosseini, SM; Khodaie-Ardakani, MR; Pourmahmoud, H; Rezaei, F; Sabzabadi, M; Salehi, B; Tabrizi, M; Yekehtaz, H, 2014)
"We aimed to assess the efficacy and tolerability of riluzole, an anti-glutamate agent with neuroprotective properties, as an adjunct to risperidone in improving negative symptoms of schizophrenia."5.19A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia. ( Akhondzadeh, S; Farokhnia, M; Hosseini, SM; Khodaie-Ardakani, MR; Pourmahmoud, H; Rezaei, F; Sabzabadi, M; Salehi, B; Tabrizi, M; Yekehtaz, H, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farokhnia, M1
Sabzabadi, M1
Pourmahmoud, H1
Khodaie-Ardakani, MR1
Hosseini, SM1
Yekehtaz, H1
Tabrizi, M1
Rezaei, F1
Salehi, B1
Akhondzadeh, S1
Pollack, MH1

Reviews

1 review available for riluzole and Chronic Illness

ArticleYear
Refractory generalized anxiety disorder.
    The Journal of clinical psychiatry, 2009, Volume: 70 Suppl 2

    Topics: Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiet

2009

Trials

1 trial available for riluzole and Chronic Illness

ArticleYear
A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia.
    Psychopharmacology, 2014, Volume: 231, Issue:3

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Excita

2014